2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$13.12+$0.10 (+0.80%)
Price as of Aug 03, 2026 4:45 AM EDT- $10.4BMarket Cap
- -51.90%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$13.12+$0.10 (+0.80%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.02 | ||
Change | -$0.42 (-3.12%) | ||
Open | $13.44 | ||
High | $13.59 | ||
Low | $13.01 | ||
Previous Close | $13.44 | ||
Volume | 3,995,135 | ||
30-Day Average Volume | 3,822,784 | ||
1-Week Change | -4.69% | ||
1-Month Change | -10.64% | ||
1-Year Change | -51.90% | ||
3-Year Change | 520.00% | ||
5-Year Change | 77.63% | ||
Fundamentals | |||
Shares Outstanding | 797.7M | ||
Total Assets | $752.2M | ||
Market Cap | $10.4B | ||
Enterprise Value | $10.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$215.7M | ||
Free Cash Flow | -$142.0M | ||
EBIT | -$215.7M | ||
EBITDA | -$215.7M | ||
Net Working Capital | $617.0M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 16 | ||
P/E | -47 | ||
PEG | 3 | ||
Price/Free Cash Flow | -73 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue